Association of killer cell immunoglobulin-like receptor polymorphisms with chronic hepatitis C and responses to therapy in Brazil
AUTOR(ES)
Vasconcelos, Janaina Mota de, Móia, Lizomar de Jesus Maués Pereira, Amaral, Ivanete do Socorro Abraçado, Miranda, Esther Castello Branco Mello, CicaliseTakeshita, Louise Yukari, Oliveira, Layanna Freitas de, Mendes, Lilian de Araújo Melo, Sastre, Danuta, Tamegão-Lopes, Bruna Pedroso, Pedroza, Larysse Santa Rosa de Aquino, Santos, Sidney Emanuel Batista dos, Soares, Manoel do Carmo Pereira, Araújo, Marialva Tereza Ferreira de, Bandeira, Camila Lucas, Silva, Adriana Maria Paixão de Sousa da, Medeiros, Zilene Lameira de, Sena, Leonardo, Demachki, Samia, Santos, Eduardo José Melo dos
FONTE
Genet. Mol. Biol.
DATA DE PUBLICAÇÃO
2013
RESUMO
Soroprevalence for Hepatitis C virus is reported as 2.12% in Northern Brazil, with about 50% of the patients exhibiting a sustained virological response (SVR). Aiming to associate polymorphisms in Killer Cell Immunoglobulin-like Receptors (KIR) with chronic hepatitis C and therapy responses we investigated 125 chronic patients and 345 controls. Additionally, 48 ancestry markers were genotyped to control for population stratification. The frequency of the KIR2DL2 and KIR2DL2+HLA-C Asp80 gene and ligand was higher in chronic infected patients than in controls (p < 0.0009, OR = 3.4; p = 0.001, OR = 3.45). In fact, KIR2DL3 is a weaker inhibitor of NK activity than KIR2DL2, which could explain the association of KIR2DL2 with chronic infection. Moreover, KIR2DS2 and KIR2DS2+HLA-C Asp80 (p < 0.0001, OR = 2.51; p = 0.0084, OR = 2.62) and KIR2DS3 (p < 0.0001; OR = 2.57) were associated with chronic infection, independently from KIR2DL2. No differences in ancestry composition were observed between control and patients, even with respect to therapy response groups. The allelic profile KIR2DL2/KIR2DS2/KIR2DS3 was associated with the chronic hepatitis C (p < 0.0001; OR = 3). Furthermore, the patients also showed a higher mean number of activating genes and a lower frequency of the homozygous AA profile, which is likely secondary to the association with non-AA and/or activating genes. In addition, the KIR2DS5 allele was associated with SVR (p = 0.0261; OR = 0.184).The ancestry analysis of samples ruled out any effects of population substructuring and did not evidence interethnic differences in therapy response, as suggested in previous studies.
Documentos Relacionados
- Epigenetic regulation of killer immunoglobulin–like receptor expression in T cells
- Importance of killer immunoglobulin-like receptors in allogeneic hematopoietic stem cell transplantation
- Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies
- Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates
- Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias